AlphAIAlphAI — Financial news for AI agents
financialcontent.comJUL 295 min read$MAX

MediaAlpha (NYSE:MAX) Reports Upbeat Q2 CY2026, Guides for Strong Sales Next Quarter

MediaAlpha (NYSE:MAX) reported Q2 CY2026 revenue of $316.9 million, up 25.9% year over year, ahead of Wall Street expectations. Midpoint guidance for next-quarter revenue was $342.5 million, slightly above estimates. GAAP EPS was $0.65, well above consensus. The article also cites full-year EPS guidance of $1.11.

Original reporting
financialcontent.com
Published Jul 29, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 29, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
MediaAlpha (NYSE:MAX) Reports Upbeat Q2 CY2026, Guides for Strong Sales Next Quarter — source image
Source · financialcontent.com
Decision brief

The 30-second read

$MAXBullishMed
01

Why it matters

The key tradable inputs are the Q2 revenue and GAAP EPS beat versus expectations and the next-quarter revenue guidance midpoint that is modestly above analysts’ estimates.

02

Market read

A revenue and EPS beat with slightly better-than-expected next-quarter guidance can drive estimate revisions and near-term positioning, even if forward EPS is expected to soften.

03

What to watch

Adjusted operating margin is discussed as improving, but the article does not break out drivers (pricing vs mix vs cost control), leaving uncertainty around sustainability.

Relevance 8/10Novelty 7/10Timing: after-hours/late-day reaction to Q2 CY2026 results and next-quarter revenue guidance

Background

MediaAlpha runs an insurance customer acquisition referral platform, connecting carriers with high-intent consumers across property-casualty, health, and life.

Company-level read

Ticker impact

$MAXBullishMedium confidence
Context

MediaAlpha reported Q2 CY2026 revenue of $316.9M (+25.9% YoY) and guided next-quarter revenue to $342.5M midpoint, above estimates.

Expected impact

Likely near-term positive bias versus pre-report expectations, with follow-through dependent on whether the guidance is sustained.

Evidence & confidence

The article provides concrete Q2 results and a specific next-quarter revenue midpoint above analysts’ estimates, which typically drives short-term repricing.

Market effects

Sector

Signals continued demand strength in insurance customer acquisition software/services, potentially supporting the group’s growth narrative.

Regional

No specific regional impact described beyond US-listed company results.

Global

No explicit global drivers mentioned; impact appears company-specific.

Counterpoint

What could challenge this read

Despite the beat, the article notes Wall Street expects full-year EPS to decline 31.6%, which could cap upside if investors focus on earnings durability.

Key entities

  • company
    MediaAlpha

    Insurance customer acquisition platform reporting Q2 CY2026 results and next-quarter revenue guidance.

  • person
    Steve Yi

    CEO quoted saying demand broadened across the marketplace.

Read at source← All news

Related articles

SEP 1
$SBGIMed

Q2 Earnings Outperformers: Sinclair (NASDAQ:SBGI) And The Rest Of The Media & Entertainment Stocks

Sinclair (SBGI) stock rose 30.9% to $51.46 after Q2 earnings. Getty Images (GETY) reported $229.1M revenue, down 2.5% YoY, missing estimates; stock fell 44.4% to $0.25. MediaAlpha (MAX) reported $316.9M revenue, up 25.9% YoY, beating expectations; stock down 8.5% to $12.63. Taboola (TBLA) reported $476.8M revenue, up 2.4% YoY, missing estimates; stock down 28.6% to $3.78.

finance.yahoo.com3 min
JUL 29
$MAXHigh

MEDIAALPHA ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS

MediaAlpha, Inc. (MAX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MEDIAALPHA ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS Second Quarter Revenue Growth of 26%; Record Revenue of $316.9 million Second Quarter Net Income of $41.8 million; Adjusted EBITDA (1) of $29.3 million Repurchased over $41 million of stock during the First H

SEC EDGAR 8-K4 min
OCT 23
$WCNMedAI 8/10

WCN Q3 deep dive: margin expansion and sustainability initiatives drive optimism for 2027

Waste Connections (WCN) reported Q3 revenue of $2.64B, beating estimates by 1.2%, and adjusted EPS of $1.58, beating by 3.9%. The company raised its full-year revenue guidance to $10.09B. Operating margin expanded to 20.5% from 17.9% YoY. Management highlighted margin expansion from pricing discipline, landfill volume recovery, and sustainability investments, including RNG facilities. The board approved a 10% dividend increase and $1B in share repurchases.

finance.yahoo.com2 min
OCT 23
$BEMedAI 8/10

Another AI power stock plunges 11% despite earnings beat

Bloom Energy (BE) shares fell 11% on Oct. 23 despite beating Q3 earnings estimates and raising its 2026 outlook. The company reported adjusted earnings of $0.94 per share and revenue of $1.24 billion, both above expectations. However, negative free cash flow and broader market sentiment weighed on the stock. Analysts remain divided on price targets, with JPMorgan lowering its target to $292 and Morgan Stanley raising it to $335.

finance.yahoo.com2 min
OCT 23
$CACIHighAI 9/10

CACI Q3 deep dive: margins rise on technology mix, modest revenue miss offsets robust contract wins

CACI reported Q3 revenue of $2.47B, missing estimates by 1.4%, but beat EPS and EBITDA expectations. The company raised full-year revenue and EPS guidance. Margins improved due to higher-margin technology contracts, and backlog remained steady at $34B. Growth was driven by defense and space contracts, with new manufacturing centers supporting future production.

finance.yahoo.com3 min
OCT 23
$MEDPMedAI 8/10

MEDP Q3 deep dive: bookings strength drives growth, margin expansion continues

MEDP reported Q3 revenue of $716M, beating estimates, with EPS of $4.84 and adjusted EBITDA of $172.1M. The company reconfirmed full-year revenue guidance of $2.85B and raised EPS guidance to $18.15. Growth was driven by strong bookings in oncology research and margin expansion from a favorable project mix. Management highlighted stable competition, low turnover, and sustained bookings momentum, but noted project cancellations as a watchpoint.

finance.yahoo.com2 min